Brief: Hepion Pharmaceuticals Says Gary Jacob Resigned From The Board Of Directors
Feb 20 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O :
* HEPION PHARMACEUTICALS INC - GARY JACOB RESIGNED FROM THE
BOARD
OF DIRECTORS OF HEPION PHARMACEUTICALS, INC.
* HEPION PHARMACEUTICALS INC - GARY JACOB WAS CHAIRMAN OF CO
AND
THE BOARD OF DIRECTORS APPOINTED JOHN BRANCACCIO AS CHAIRMAN
Further company coverage: HEPA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement